JUNO THERAPEUTICS INC's ticker is JUNO and the CUSIP is 48205A109. A total of 163 filers reported holding JUNO THERAPEUTICS INC in Q4 2015. The put-call ratio across all filers is 2.35 and the average weighting 1.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2017 | $1,226,000 | +318.4% | 26,830 | +310.7% | 0.01% | +300.0% |
Q3 2017 | $293,000 | +17.7% | 6,533 | +0.9% | 0.00% | 0.0% |
Q2 2016 | $249,000 | +16.9% | 6,475 | +15.9% | 0.00% | +100.0% |
Q1 2016 | $213,000 | +15.1% | 5,589 | +32.7% | 0.00% | 0.0% |
Q4 2015 | $185,000 | – | 4,212 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Crestline Management, LP | 25,948,799 | $1,055,857,000 | 100.00% |
Omega Fund Management, LLC | 1,329,512 | $54,098,000 | 30.46% |
SOUND ENERGY PARTNERS, INC. | 25,800 | $1,050,000 | 2.12% |
Graticule Asia Macro Advisors LLC | 435,205 | $17,708,000 | 2.06% |
BB BIOTECH AG | 1,305,000 | $53,100,000 | 1.68% |
Kazazian Asset Management, LLC | 13,376 | $544,000 | 0.69% |
Rock Springs Capital Management LP | 197,001 | $8,016,000 | 0.65% |
TURNER INVESTMENTS LLC | 69,680 | $2,835,000 | 0.57% |
MIZUHO SECURITIES USA LLC | 49,600 | $2,018,000 | 0.52% |
Private Capital Advisors, Inc. | 27,900 | $1,135,000 | 0.48% |